Project Grant HT94252411067
Award Date
11/1/24
Completion Date
10/31/28
Dollars Obligated
$2.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Allegheny-West, PA 15212, USA
Similar Awards
This $3,333,240 Department of Defense Project Grant awarded under the Military Medical Research and Development program (CFDA 12.420) will fund research by the Allegheny Singer Research Institute (AHN Research Institute) to investigate the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum. The award has a performance period from June 1, 2025 to May 31, 2029. As a sophisticated medical research organization, the Allegheny Singer Research Institute...
This $4,029,612 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports the "INFLUENCE TRIAL: IMPROVING EVENT-FREE SURVIVAL BY OPTIMIZING FLUDARABINE EXPOSURE DURING LYMPHODEPLETION FOR CAR T CELL THERAPY" research initiative. The grant, awarded to the Sloan-Kettering Institute for Cancer Research, a prominent non-profit cancer research organization, will fund advanced oncology research focused on...
The University of Pittsburgh has been awarded a $1,541,823 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development federal grant program (CFDA 12.420) to develop fast treatment methods for metastatic cancer patients with pleural disease. The grant, which runs from November 1, 2024 to October 31, 2028, will fund the University's research efforts to explore innovative approaches to disease prevention, diagnosis, treatment, and management of these...
The Children's Research Institute received a $709,638 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research efforts from May 2021 through April 2024 to enhance T-cell immunotherapy treatments for pediatric patients with relapsed or refractory solid tumors. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
The Sloan-Kettering Institute For Cancer Research was awarded a $1,593,000 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) on September 30, 2022. The grant-funded project will investigate ceramide's role in mediating COVID-19 vascular injury and acute respiratory distress syndrome through basic, applied, and advanced biomedical research. Specifically, the Institute will conduct research to develop medical solutions...
The Sloan-Kettering Institute for Cancer Research was awarded a $707,997 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to dissect ovarian cancer tumor-immune microenvironments through 3D in situ molecular profiling from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...
The Institute For Cancer Research was awarded a $188,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 15, 2024, supports research to exploit adenosine signaling in the tumor microenvironment to boost kidney cancer immunotherapy. This work is intended to transform health care for military service members and the public through innovative and impactful cancer research. The...
The Sloan-Kettering Institute For Cancer Research was awarded a $619,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The two-year award will fund research to identify and target mechanisms of lung cancer initiation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical...
The Department of the Army Medical Command awarded a $695,089 Project Grant to the Dana-Farber Cancer Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2022 to May 31, 2025 to develop noninvasive diagnosis of immune checkpoint inhibitor-associated myocarditis. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative...
The Sloan-Kettering Institute For Cancer Research was awarded a $1,062,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop therapeutic activation of immunogenic cell death to improve immunotherapy for kidney cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...